Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term GROWTH. Found 12 abstracts

Garcia JA, Hudes GR, Choueiri TK, Stadler WM, Wood LS, Gurtler J, Bhatia S, Joshi A, Hozak RR, Xu YH, Schwartz JD, Thompson JA. A Phase 2, Single-Arm Study of Ramucirumab in Patients With Metastatic Renal Cell Carcinoma With Disease Progression on or Intolerance to Tyrosine Kinase Inhibitor Therapy. Cancer. 2014 Jun;120(11):1647-55.   PMCID: No NIH funding
Jenkins S, Raghuraman N, Eltoum I, Carpenter M, Russo J, Lamartiniere CA. Oral Exposure to Bisphenol A Increases Dimethylbenzanthracene-Induced Mammary Cancer in Rats. Environmental Health Perspectives. 2009 Jun;117(6):910-5.   PMCID: PMC2702405
Adjei AA, Cohen RB, Franklin W, Morris C, Wilson D, Molina JR, Hanson LJ, Gore L, Chow L, Leong S, Maloney L, Gordon G, Simmons H, Marlow A, Litwiler K, Brown S, Poch G, Kane K, Haney J, Eckhardt SG. Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers. Journal of Clinical Oncology. 2008 May;26(13):2139-46.
Huang QH, Gumireddy K, Schrier M, Le Sage C, Nagel R, Nair S, Egan DA, Li AP, Huang GH, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Pure E, Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature Cell Biology. 2008 Feb;10(2):202-U83.
Lee H, Kim D, Dan HC, Wu EL, Gritsko TM, Cao CH, Nicosia SV, Golemis EA, Liu WG, Coppola D, Brem SS, Testa JR, Cheng JQ. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein. Molecular and Cellular Biology. 2007 Mar;27(6):2103-19.
Mellert H, Sykes SM, Murphy ME, McMahon SB. The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain. Cell cycle (Georgetown, Tex). 2007 Jun;6(11):1304-6.
Murph M, Tanaka T, Pang J, Felix E, Liu S, Trost R, Godwin AK, Newman R, Mills G. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: Potential biomarkers for cancer diagnosis. Methods in Enzymology . 2007 Jan;433:1-25.
O'Neill GM, Seo S, Serebriiskii HG, Lessin SR, Golemis EA. A new central scaffold for metastasis: Parsing HEF1le/Cas-L/NEDD9. Cancer Research. 2007 Oct;67(19):8975-9.
Oyama K, Okawa T, Nakagawa H, Takaoka M, Andl CD, Kim SH, Klein-Szanto A, Diehl JA, Herlyn M, El-Deiry W, Rustgi AK. AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture. Oncogene. 2007 Apr;26(16):2353-64.
Thallapally PK, Jetti RK, Katz AK, Carrell HL, Singh K, Lahiri K, Kotha S, Boese R, Desiraju GR. Polymorphism of 1,3,5-trinitrobenzene induced by a trisindane additive. Angewandte Chemie-International Edition. 2004 Jan;43(9):1149-55.
Astrinidis A, Senapedis W, Coleman TR, Henske EP. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1 cyclin B. Journal of Biological Chemistry. 2003 Dec;278(51):51372-9.
Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, Fusco A, Santoro M. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nature medicine. 2002 Oct;8(10):1136-44.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term GROWTH

GROWTH EXPRESSION CELLS ACTIVATION CARCINOMA CANCER TUMORS KINASE BREAST-CANCER PROLIFERATION DROSOPHILA polymorphism CADHERIN NUCLEATION SUNITINIB POTENT CELL-SURVIVAL TUMOR TUMOR-SUPPRESSOR GENE LYSOPHOSPHATIDIC ACID PRODUCTION BEVACIZUMAB AKT VIVO PREDICT proliferation ADHESION MOLECULES CELL-ADHESION AUTOTAXIN NPP-2 AUXILIARIES KINASE-B SORAFENIB III TRIAL TP53 CARCINOMAS SUBCELLULAR-LOCALIZATION RECEPTOR COACTIVATOR AIB1 P70 S6 KINASE OVARIAN-CANCER MYC renal cell carcinoma RHEB SUSCEPTIBILITY MEK INHIBITOR phase 2 PROTEIN-KINASE CHLORONITROBENZENE CRYSTALS p53 QUANTITATIVE-ANALYSIS PHENOTYPE TRINITROBENZENE SUPPRESSION additives p19ARF METASTABLE POLYMORPH MDM2 NF2 ramucirumab COLON IN-VITRO GENE-REGULATION EGFR 3-KINASE ADHESION INK4A HEF1 CDKN2A IDENTIFICATION KeyWords Plus: apoptosis SPHINGOSINE KINASE-1 AKT ACTIVATION organotypic culture DEATH MICE KLF6 ARCHITECTURE PROSTATE-CANCER KINETICS KERATINOCYTES monoclonal ERM PROTEINS MESSENGER-RNA TYPE-2 GENE-PRODUCT PROGNOSTIC-FACTORS PATHWAY CDK-INHIBITORS hMOF TAMOXIFEN RESISTANCE GLIOBLASTOMA-MULTIFORME MERLIN PHOSPHORYLATION ARF TUMOR-SUPPRESSOR POLAR AXES ESTROGEN K120 antibody SELECTION Oncology TIP60 PHOSPHATIDIC-ACID CAS-L STABILIZATION inhibition TAILOR-MADE ADDITIVES crystal growth metastatic TSC1 GENE P53-DEPENDENT APOPTOSIS PROTEIN MUTATIONS acetylation CD44S EXPRESSION AKT PATHWAY TRAFFICKING differentiation bisphenol A apoptosis-mammary cancer-proliferation-steroid receptor coactivators SIGNALING PATHWAY P27 ARF LOCUS GLAND DEVELOPMENT PERINATAL EXPOSURE
Last updated on Thursday, April 02, 2020